Simon F. Campbell

3.0k total citations
54 papers, 1.9k citations indexed

About

Simon F. Campbell is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Simon F. Campbell has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 22 papers in Molecular Biology and 9 papers in Pharmaceutical Science. Recurrent topics in Simon F. Campbell's work include Synthesis and Biological Evaluation (11 papers), Phenothiazines and Benzothiazines Synthesis and Activities (9 papers) and Fluorine in Organic Chemistry (7 papers). Simon F. Campbell is often cited by papers focused on Synthesis and Biological Evaluation (11 papers), Phenothiazines and Benzothiazines Synthesis and Activities (9 papers) and Fluorine in Organic Chemistry (7 papers). Simon F. Campbell collaborates with scholars based in United Kingdom, Brazil and United States. Simon F. Campbell's co-authors include Janet M. Thornton, Simon J. Hubbard, Michael Palmer, Peter E. Cross, Roger A. Burges, Donald G. Gardiner, Kenneth J. Blackburn, Philip Kocieński, John Arrowsmith and R. Stephens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Molecular Biology.

In The Last Decade

Simon F. Campbell

54 papers receiving 1.8k citations

Peers

Countries citing papers authored by Simon F. Campbell

Since Specialization

Citations

This map shows the geographic impact of Simon F. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon F. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon F. Campbell more than expected).

Fields of papers citing papers by Simon F. Campbell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon F. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon F. Campbell. The network helps show where Simon F. Campbell may publish in the future.

Co-authorship network of co-authors of Simon F. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Simon F. Campbell. A scholar is included among the top collaborators of Simon F. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon F. Campbell. Simon F. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease 2022 ·European Journal of Medicinal Chemistry ·Celso de Oliveira Rezende Júnior, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Adriano D. Andricopulo, An Matheeussen, Natascha Van Pelt, Guy Caljon, Louis Maes, Simon F. Campbell, Jadel M. Kratz, Charles E. Mowbray, Luiz C. Dias	5
2	2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling 2021 ·PLoS neglected tropical diseases ·(unknown), Celso de Oliveira Rezende Júnior, (unknown), (unknown), (unknown), Leonardo L. G. Ferreira, (unknown), (unknown), Adriano D. Andricopulo, (unknown), Sílvia Reni Bortolin Uliana, An Matheeussen, Guy Caljon, Louis Maes, Simon F. Campbell, Jadel M. Kratz, Charles E. Mowbray, Luiz C. Dias	11
3	Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents 2020 ·RSC Medicinal Chemistry ·(unknown), Marco A. Dessoy, An Matheeussen, Louis Maes, Guy Caljon, Leonardo L. G. Ferreira, (unknown), (unknown), Adriano D. Andricopulo, Simon F. Campbell, Jadel M. Kratz, Charles E. Mowbray, Luiz C. Dias	5
4	Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans 2016 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Eileen Ryan, Gong Chen, Karen L. White, Susan A. Charman, Simon F. Campbell, Paul Willis, Luiz C. Dias	17
5	Simon Campbell on the ups and downs of drug discovery and development 2005 ·Drug Discovery Today ·(unknown), (unknown), Simon F. Campbell	1
6	Substrate recognition by proteinases 1992 ·Faraday Discussions ·Simon J. Hubbard, Janet M. Thornton, Simon F. Campbell	14
7	Molecular Recognition and Drug Design 1991 ·Química Nova ·Simon F. Campbell	2
8	Long-acting dihydropyridine calcium antagonists. 6. Structure-activity relationships around 4-(2,3-dichlorophenyl)-3-(ethoxycarbonyl)-2-[(2-hydroxyethoxy)methyl]-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine 1991 ·Journal of Medicinal Chemistry ·David Alker, Simon F. Campbell, Peter E. Cross	13
9	Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists 1990 ·Journal of Medicinal Chemistry ·David Alker, Simon F. Campbell, Peter E. Cross, Roger A. Burges, (unknown), Donald G. Gardiner	28
10	Long-acting dihydropyridine calcium antagonists. 5. Synthesis and structure-activity relationships for a series of 2-[[(N-substituted-heterocyclyl)ethoxy]methyl]-1,4-dihydropyridine calcium antagonists 1990 ·Journal of Medicinal Chemistry ·David Alker, Simon F. Campbell, Peter E. Cross, Roger A. Burges, (unknown), Donald G. Gardiner	23
11	2(1H)-Quinolinones with cardiac stimulant activity. 2. Synthesis and biological activities of 6-(N-linked, five-membered heteroaryl) derivatives 1989 ·Journal of Medicinal Chemistry ·(unknown), Andrew Bell, Simon F. Campbell, Peter Ellis, (unknown), David S. Morris, D. Allen Roberts, (unknown), (unknown), Mark H. Stefaniak	39
12	2(1H)-Quinolinones with cardiac stimulant activity. 3. Synthesis and biological properties of 6-imidazol-1-yl derivatives 1989 ·Journal of Medicinal Chemistry ·Andrew Bell, Simon F. Campbell, David S. Morris, David A. Roberts, Mark H. Stefaniak	13
13	7-Heteroaryl-1,2,3,5-tetrahydroimidazol[2,1-b]quinazolin-2(1H)-one derivatives with cardiac stimulant activity 1989 ·Journal of Medicinal Chemistry ·Andrew Bell, Simon F. Campbell, D. Allen Roberts, (unknown)	9
14	UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic 1989 ·Biochemical and Biophysical Research Communications ·John C. Danilewicz, Paul L. Barclay, I. T. Barnish, David Brown, Simon F. Campbell, Kim James, (unknown), N.K. Terrett, Martin Wythes	53
15	Long acting dihydropyridine calcium antagonists. 2. 2-[2-aminoheterocycloethoxy]methyl derivatives 1989 ·Journal of Medicinal Chemistry ·John Arrowsmith, Simon F. Campbell, Peter E. Cross, Roger A. Burges, Donald G. Gardiner	16
16	2,4-Diamino-6,7-dimethoxyquinoline derivatives as .alpha.1-adrenoceptor antagonists and antihypertensive agents 1988 ·Journal of Medicinal Chemistry ·Simon F. Campbell, (unknown), Michael Palmer	145
17	2(1H)-Quinolinones with cardiac stimulant activity. 1. Synthesis and biological activities of (six-membered heteroaryl)-substituted derivatives 1988 ·Journal of Medicinal Chemistry ·(unknown), Andrew Bell, Simon F. Campbell, Peter Ellis, (unknown), David A. Roberts, (unknown), (unknown), Mark H. Stefaniak	44
18	2,4-Diamino-6,7-dimethoxyquinazolines. 4. 2-[4-(Substituted oxyethoxy)piperidino] derivatives as .alpha.1-adrenoceptor antagonists and antihypertensive agents 1988 ·Journal of Medicinal Chemistry ·Simon F. Campbell, John C. Danilewicz, (unknown), (unknown)	13
19	1,3-Diamino-6,7-dimethoxyisoquinoline derivatives as potential .alpha.1-adrenoceptor antagonists 1988 ·Journal of Medicinal Chemistry ·Jon Bordner, Simon F. Campbell, Michael Palmer, (unknown)	17
20	The geometries of interacting arginine‐carboxyls in proteins 1987 ·FEBS Letters ·Juswinder Singh, Janet M. Thornton, M. Snarey, Simon F. Campbell	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact